INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

NATIXIS ADVISORS, L.P.'s Holding History (CIK: 0001018331)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 25,085 Value ($000) $2 Avg Close — Range —
Q3 2024
Shares 24,583 Value ($000) $2 Avg Close — Range —
Q2 2024
Shares 31,660 Value ($000) $2 Avg Close — Range —
Q1 2024
Shares 35,252 Value ($000) $2 Avg Close — Range —
Q4 2023
Shares 33,888 Value ($000) $2 Avg Close — Range —
Q3 2023
Shares 31,334 Value ($000) $2 Avg Close — Range —
Q2 2023
Shares 33,844 Value ($000) $2 Avg Close — Range —
Q1 2023
Shares 27,459 Value ($000) $1 Avg Close — Range —
Q4 2022
Shares 27,448 Value ($000) $1 Avg Close — Range —
Q3 2022
Shares 21,006 Value ($000) $977 Avg Close — Range —
Q2 2022
Shares 18,907 Value ($000) $1,079 Avg Close — Range —
Q1 2022
Shares 18,165 Value ($000) $1,112 Avg Close — Range —
Q4 2021
Shares 10,607 Value ($000) $555 Avg Close — Range —
Q4 2020
Shares 10,758 Value ($000) $342 Avg Close — Range —